Orca Bio

Payer Field Team, Account Director

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Position Overview

  • Location Type: Remote (Multiple Regions)
  • Employment Type: Regular, Full-Time Employee
  • Salary: (Salary information not provided in the text)

Orca Bio is a late-stage biotechnology company focused on redefining the transplant process through next-generation cell therapies. They aim to provide significantly better survival rates with dramatically fewer risks by replacing patients' blood and immune systems with healthy ones. The Account Director role within the US Payer Field team is crucial for securing favorable coverage and reimbursement for Orca Bio's products through regional, national, and government payers. This role involves engaging with payers, academic hospitals, and health systems to ensure broad and timely patient access.

Requirements

  • Strong understanding of healthcare reimbursement and payer landscape.
  • Experience in pharmaceutical or biotechnology sales, particularly in access or managed care.
  • Excellent communication, presentation, and interpersonal skills.
  • Ability to analyze scientific data and translate it into a compelling value proposition for payers.
  • Collaboration skills to work effectively with cross-functional teams (Field Sales, Medical Affairs, Legal, Quality, and Marketing).
  • Subject matter expertise on access-related items including payer policy, pricing communication, and authorized treatment center reimbursement.

Responsibilities

  • Serves as the single-point-of-contact for all Authorized Treatment Centers (ATCs) with respect to field-related payer-access engagements (including onboarding).
  • Develops and executes Payer Strategy for assigned regional and national payer accounts, focusing on securing access to ORCA-T at launch and ongoing payer segmentation.
  • Presents analysis of scientific data, clinical practice goals, guidelines, and anticipated economic program outcomes to support the product’s value proposition.
  • Utilizes clinical expertise of Medical Science Liaisons or medical providers in delivering comprehensive product and disease state presentations.
  • Delivers and maintains favorable access, advantageous payer medical policy, and appropriate reimbursement for ORCA-T at regional & national payer accounts.
  • Accountable for partnerships with targeted Academic Hospitals/Health Systems to ensure patient access for ORCA-T on a case-by-case basis.
  • Frequent interactions with Orca’s Case Management team to resolve patient access issues.

Application Instructions

  • (Application instructions not provided in the text)

Company Information

  • Company: Orca Bio
  • Industry: Biotechnology
  • Mission: To redefine the transplant process by developing next-generation cell therapies that provide significantly better survival rates with dramatically fewer risks.

Skills

Healthcare reimbursement
Payer landscape
Pharmaceutical sales
Biotechnology sales
Access or managed care
Communication
Presentation
Interpersonal skills
Scientific data analysis
Value proposition development
Cross-functional collaboration
Payer policy
Pricing communication
Authorized Treatment Center reimbursement

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI